Drugs / iPS differentiated cardiomyocytes
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT03759405 | Dec 2022 → Dec 2024 | heart failure | Beijing University of Chinese Medicine | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | iPS differentiated cardiomyocytes | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03759405 ↗ |
| Action | Restore | “Repair of injured myocardium by vein transplantation with autologous iPS differentiated cardiomyocytes” NCT03759405 ↗ |